ARTICLE | Company News
Eukarion Inc. other research news
April 24, 2000 7:00 AM UTC
Eukarion received a $1.3 million Phase II SBIR grant from the National Institute of General Medical Sciences to develop its SCSs, which mimic the activity of the superoxide dismutase (SOD) and catalas...